| Autor: |
Arevalo J.F., Liu T.Y.A., Wu L., Lasave A.F., Farah M., Maia M., Penha F.M., Rodrigues E.B., Morales-Canton V., Fromow-Guerra J., Guerrero-Naranjo J.L., Dalma-Weiszhausz J., Velez-Montoya R., Quiroz-Mercado H., Rodriguez F.J., Gomez F.E., Brieke A.C., Goveto A., Berrocal M.H., Cruz-Villegas V., Graue-Wiechers F., Lozano-Rechy D., Fulda-Graue E., Roca J.A., Hernández A., Saravia M.J., Schlaen A., Rojas J., Ingolotti M., Avila M., Carla L., Cardillo J., Jorge R., Carpentier C., Verdaguer J., Verdaguer J.I., Sepúlveda G., Alezzandrini A., Garcia B., Zas M., Gallego-Pinazo R., Diaz-Llopis M., Dolz-Marco R., Figueroa M., Contreras I., Ruiz-Casas D., Pan-American Collaborative Retina Study Group (PACORES) |
| Jazyk: |
angličtina |
| Rok vydání: |
2018 |
| Předmět: |
|
| Zdroj: |
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario |
| Popis: |
The advent of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications has revolutionized the treatment of diabetic eye diseases. Herein, we report the outcomes of clinical studies carried out by the Pan-American Collaborative Retina Study Group (PACORES), with a specific focus on the efficacy of intravitreal bevacizumab in the management of diabetic macular edema and proliferative diabetic retinopathy. We will also discuss the use of intravitreal bevaci-zumab as a preoperative, adjuvant therapy before vitrectomy for prolif-erative diabetic retinopathy. Copyright © 2017 by Asia Pacific Academy of Ophthalmology. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
